Page 1207 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 66 Acute Lymphoblastic Leukemia in Adults 1054.e1

REFERENCES lymphoblastic leukemia: a retrospective study from the European Group
for Blood and Marrow Transplantation. Haematologica 93:303, 2008.
1. Larson RA, Dodge RK, Burns CP, et al: A five-drug remission induction 19. Stein AS, Palmer JM, O’Donnell MR, et al: Reduced-intensity condi-
regimen with intensive consolidation for adults with acute lymphoblastic tioning followed by peripheral blood stem cell transplantation for adult
leukemia: cancer and leukemia group B study 8811. Blood 85:2025, patients with high-risk acute lymphoblastic leukemia. Biol Blood Marrow
1995. Transplant 15:1407, 2009.
2. Larson RA, Dodge RK, Linker CA, et al: A randomized controlled trial 20. Bachanova V, Verneris MR, DeFor T, et al: Prolonged survival in adults
of filgrastim during remission induction and consolidation chemotherapy with acute lymphoblastic leukemia after reduced-intensity conditioning
for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood with cord blood or sibling donor transplantation. Blood 113:2902, 2009.
92:1556, 1998. 21. Ram R, Storb R, Sandmaier BM, et al: Non-myeloablative conditioning
3. Kantarjian H, Thomas D, O’Brien S, et al: Long-term follow-up results with allogeneic hematopoietic cell transplantation for the treatment of
of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and high-risk acute lymphoblastic leukemia. Haematologica 96:1113, 2011.
dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute 22. Thomas DA, Faderl S, Cortes J, et al: Treatment of Philadelphia
lymphocytic leukemia. Cancer 101:2788, 2004. chromosome-positive acute lymphocytic leukemia with hyper-CVAD
4. Gökbuget N, Arnold R, Buechner Th, et al: Intensification of induction and imatinib mesylate. Blood 103:4396, 2004.
and consolidation improves only subgroups of adult ALL: analysis of 23. Thomas DA, O’Brien SM, et al: Long-term outcome after hyper-CVAD
1200 patients in GMALL study 05/93. Blood 98:802a, 2001. and imatinib (IM) for de novo or minimally treated Philadelphia
5. Gökbuget N, Arnold R, et al: Improved outcome in high risk and chromosome-positive acute lymphoblastic leukemia (Ph-ALL). J Clin
very high risk ALL by risk adapted SCT and in standard risk ALL by Oncol 28:15s, 2010.
intensive chemotherapy in 713 adult ALL patients treated according to 24. Towatari M, Yanada M, Usui N, et al: Combination of intensive chemo-
the prospective GMALL study 07/2003. Blood 110:12a, 2007. therapy and imatinib can rapidly induce high-quality complete remission
6. Thomas X, Boiron JM, Huguet F, et al: Outcome of treatment in adults for a majority of patients with newly diagnosed BCR-ABL-positive acute
with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin lymphoblastic leukemia. Blood 104:3507, 2004.
Oncol 22:4075, 2004. 25. Yanada M, Takeuchi J, Sugiura I, et al: High complete remission rate
7. Takeuchi J, Kyo T, Naito K, et al: Induction therapy by frequent admin- and promising outcome by combination of imatinib and chemotherapy
istration of doxorubicin with four other drugs, followed by intensive for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a
consolidation and maintenance therapy for adult acute lymphoblastic phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol
leukemia: the JALSG-ALL93 study. Leukemia 16:1259, 2002. 24:460, 2006.
8. Jinnai I, Sakura T, Tsuzuki M, et al: Intensified consolidation therapy 26. Hatta Y, Mizuta S, et al: Promising Outcome of Imatinib-Combined
with dose-escalated doxorubicin did not improve the prognosis of Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Trans-
adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. Int plantation for Philadelphia Chromosome-Positive Acute Lymphoblastic
J Hematol 92:490, 2010. Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG)
9. Annino L, Vegna ML, Camera A, et al: Treatment of adult acute lym- Ph+ALL202 Regimen. Blood 114:3090a, 2009.
phoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 27. de Labarthe A, Rousselot P, Huguet-Rigal F, et al: Imatinib combined
0288 randomized study. Blood 99:863, 2002. with induction or consolidation chemotherapy in patients with de novo
10. Goldstone AH, Richards SM, Lazarus HM, et al: In adults with standard- Philadelphia chromosome-positive acute lymphoblastic leukemia: results
risk acute lymphoblastic leukemia, the greatest benefit is achieved from of the GRAAPH-2003 study. Blood 109:1408, 2007.
a matched sibling allogeneic transplantation in first complete remission, 28. Tanguy-Schmidt A, de Labarthe A, Chalandon Y, et al: Long-term results
and an autologous transplantation is less effective than conventional of the Imatinib GRAAPH-2003 study in newly-diagnosed patients
consolidation/maintenance chemotherapy in all patients: final results of with de novo Philadelphia chromosome-positive acute lymphoblastic
the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood leukemia: a GRAALL study. Biol Blood Marrow Transplant 19:150, 2013.
111:1827, 2008. 29. Wassmann B, Pfeifer H, Goekbuget N, et al: Alternating versus concur-
11. Ribera JM, Oriol A, Bethencourt C, et al: Comparison of intensive rent schedules of imatinib and chemotherapy as front-line therapy for
chemotherapy, allogeneic or autologous stem cell transplantation as Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood
post-remission treatment for adult patients with high-risk acute lympho- 108:1469, 2006.
blastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica 30. Ottmann OG, Wassmann B, Pfeifer H, et al: Imatinib compared with
90:1346, 2005. chemotherapy as front-line treatment of elderly patients with Phila-
12. Huguet F, Leguay T, Raffoux E, et al: Pediatric-inspired therapy in adults delphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).
with Philadelphia chromosome-negative acute lymphoblastic leukemia: Cancer 109:2068, 2007.
the GRAALL-2003 study. J Clin Oncol 27:911, 2009. 31. Vignetti M, Fazi P, Cimino G, et al: Imatinib plus steroids induces
13. Hunault M, Harousseau JL, Delain M, et al: Better outcome of adult complete remissions and prolonged survival in elderly Philadelphia
acute lymphoblastic leukemia after early genoidentical allogeneic bone chromosome-positive patients with acute lymphoblastic leukemia
marrow transplantation (BMT) than after late high-dose therapy and without additional chemotherapy: results of the Gruppo Italiano Malat-
autologous BMT: a GOELAMS trial. Blood 104:3028, 2004. tie Ematologiche dell’Adulto (GIMEMA) LAL0201-B protocol. Blood
14. Cornelissen JJ, van der Holt B, Verhoef GE, et al: Myeloablative alloge- 109:3676, 2007.
neic versus autologous stem cell transplantation in adult patients with 32. Bassan R, Rossi G, Pogliani EM, et al: Chemotherapy-phased imatinib
acute lymphoblastic leukemia in first remission: a prospective sibling pulses improve long-term outcome of adult patients with Philadelphia
donor versus no-donor comparison. Blood 113:1375, 2009. chromosome-positive acute lymphoblastic leukemia: Northern Italy
15. Arnold R, Massenkeil G, Bornhäuser M, et al: Nonmyeloablative stem Leukemia Group protocol 09/00. J Clin Oncol 28:3644, 2010.
cell transplantation in adults with high-risk ALL may be effective in early 33. Fielding AK, Buck G, et al: Imatinib significantly enhances long-term
but not in advanced disease. Leukemia 16:2423, 2002. outcomes in Philadelphia positive acute lymphoblastic leukaemia; Final
16. Martino R, Giralt S, Caballero MD, et al: Allogeneic hematopoietic results of the UKALLXII/ECOG2993 trial. Blood 116:169a, 2010.
stem cell transplantation with reduced-intensity conditioning in acute 34. Cortes JE, Kim DW, Pinilla-Ibarz J, et al: A phase 2 trial of ponatinib in
lymphoblastic leukemia: a feasibility study. Haematologica 88:555, Philadelphia chromosome positive leukemias. N Engl J Med 369:1783,
2003. 2013.
17. Hamaki T, Kami M, Kanda Y, et al: Reduced-intensity stem-cell trans- 35. Ottman O, et al: Nilotinib (Tasigna®) and Chemotherapy for First-Line
plantation for adult acute lymphoblastic leukemia: a retrospective study Treatment in Elderly Patients with De Novo Philadelphia Chromosome/
of 33 patients. Bone Marrow Transplant 35:549, 2005. BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL): A Trial of
18. Mohty M, Labopin M, Tabrizzi R, et al: Reduced intensity condition- the European Working Group for Adult ALL (EWALL-PH-02). Blood
ing allogeneic stem cell transplantation for adult patients with acute 124(21):Abstract 798, 2014.